CoChat

Fibromyalgia pathogenesis explained by a neuroendocrine multistable model

Open access

The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index; 74 of the 140 sources its claims cite were checked for support.

Abstract

Fibromyalgia (FM) is a central disorder characterized by chronic pain, fatigue, insomnia, depression, and other minor symptoms. Knowledge about pathogenesis is lacking, diagnosis difficult, clinical approach puzzling, and patient management disappointing. We conducted a theoretical study based on literature data and computational analysis, aimed at developing a comprehensive model of FM pathogenesis and addressing suitable therapeutic targets. We started from the evidence that FM must involve a dysregulation of central pain processing, is female prevalent, suggesting a role for the hypothalamus-pituitary-gonadal (HPG) axis, and is stress-related, suggesting a role for the HP-adrenocortical (HPA) axis. Central pathogenesis was supposed to involve a pain processing loop system including the thalamic ventroposterolateral nucleus (VPL), the primary somatosensory cortex (SSC), and the thalamic reticular nucleus (TRN). For decreasing GABAergic and/or increasing glutamatergic transmission, the loop system crosses a bifurcation point, switching from monostable to bistable, and converging on a high-firing-rate steady state supposed to be the pathogenic condition. Thereafter, we showed that GABAergic transmission is positively correlated with gonadal-hormone-derived neurosteroids, notably allopregnanolone, whereas glutamatergic transmission is positively correlated with stress-induced glucocorticoids, notably cortisol. Finally, we built a dynamic model describing a multistable, double-inhibitory loop between HPG and HPA axes. This system has a high-HPA/low-HPG steady state, allegedly reached in females under combined premenstrual/postpartum brain allopregnanolone withdrawal and stress condition, driving the thalamocortical loop to the high-firing-rate steady state, and explaining the connection between endocrine and neural mechanisms in FM pathogenesis. Our model accounts for FM female prevalence and stress correlation, suggesting the use of neurosteroid drugs as a possible solution to currently unsolved problems in the clinical treatment of the disease.

Overview

CoChat Summary

TL;DR

The paper proposes a neuroendocrine multistable model in which combined HPG/HPA axis dynamics can weaken GABAergic and strengthen glutamatergic transmission, switching a thalamocortical pain loop to a high-firing-rate state that produces fibromyalgia. It predicts female prevalence and suggests GABAA-active neurosteroids as therapeutic candidates.

Key findings

  • In the thalamocortical loop model, for maximal glutamatergic strength b = 1, the system is monostable for GABAergic strength a > 0.265; at a = 0.265 there is a bifurcation, and below this value the system becomes bistable, acquiring a high-firing-rate steady state assumed to represent FM chronic pain.
  • Allopregnanolone withdrawal is estimated to reduce GABAergic strength to a ≈ 0.13; with physiological glutamatergic strength b = 0.5, the bifurcation point is close to but still below 0.13, whereas a 20% increase to b = 0.6 drives the bifurcation above 0.13, sufficient to induce the pathogenic state.
  • The HPG-HPA double-inhibitory loop model has 3 stable equilibrium points; the high-HPA/low-HPG equilibrium is assumed to represent the functional state leading to FM onset and to drive the thalamocortical loop to its high-firing-rate state.
  • The model predicts female prevalence: p_woman = 0.037 versus p_man = 0.005, yielding 87.2% women among FM patients, close to the reported 80–90% range; it suggests natural or synthetic GABAA-active neurosteroids as a possible new FM therapy.

Methods

  • Theoretical study based on a PubMed literature search from inception through September 2023, using keywords for gonadal hormones, glucocorticoids, neurosteroids, and endocrine axes combined with “fibromyalgia,” “pain,” “glutamate,” “GABA,” and glutamate/GABA receptor names; combined with the authors’ previous thalamocortical loop model and FM-in-pregnancy review.
  • Built a graphical and mathematical description of an endocrine loop representing HPG-HPA interaction and inferred its effects on the thalamocortical system; dynamics were analyzed using MATLAB version R2022a.
  • Used systems of differential equations with increasing and decreasing Hill functions; parameters were derived from literature data and curve fitting, including median Hill parameters from allopregnanolone-GABAA and gonadal hormone/corticosteroid datasets.

Limitations

  • The paper states the model is a hypothesis that must be tested in future research; numerical values were estimated from indirect data and are not expected to exactly measure real transition processes, and the model does not predict the frequency of such occurrences in the population.
  • The paper states that existing symptomatic animal models (stress-based, acid saline, reserpine) disregard brain networks, the HPG axis, and HPA-HPG interaction, making them unsuitable as validating tests; lack of knowledge about FM pathogenesis hinders molecular and cellular models.
  • Evident from the text: the study reports no new empirical or clinical data, relies on literature-derived representative values and assumptions (e.g., brain/plasma ratio estimates, finasteride-induced reduction), and does not clinically validate the proposed neurosteroid therapy in FM.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0303573

Cites

166 of 166 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig 1 Simplified diagram of the thalamocortical loop considered in our previous FM model. Blue lines with arrowhead: excitatory glutamatergic connections; red lines with hammer endings: inhibitory GABAergic connections.
Fig 1 Simplified diagram of the thalamocortical loop considered in our previous FM model. Blue lines with arrowhead: excitatory glutamatergic connections; red lines with hammer endings: inhibitory GABAergic connections.CC BY · PubMed Central
Fig 2 Influence on the thalamocortical system dynamics exerted by the coefficients of the differential equation variables. The coefficient b shows a positive, non-linear correlation with a^, the bifurcation value of a. The coefficient θ influences the steepness of the correlation curve. The pink area highlights a range of b values within which the variation of θ has scarce influence on the corresponding values of a^.
Fig 2 Influence on the thalamocortical system dynamics exerted by the coefficients of the differential equation variables. The coefficient b shows a positive, non-linear correlation with a^, the bifurcation value of a. The coefficient θ influences the steepness of the correlation curve. The pink area highlights a range of b values within which the variation of θ has scarce influence on the corresponding values of a^.CC BY · PubMed Central
Fig 3 Relationship between estimated allopregnanolone brain levels and the strength of GABAergic transmission, expressed by the coefficient a, as derived from Eq (4). Top panel. The pink band indicates the transition zone separating two ranges of allopregnanolone where different effects on the GABAA receptor are prevalent: In the lower range the effect on GABAA α4 subunit expression, while in the higher range the positive allosteric modulation on GABAA activity. The points corresponding to allopregnanolone concentrations and a values at the follicular and luteal phases, and the value of the bifurcation point at the maximal glutamatergic strength (a^=0.265,b=1), are indicated. Bottom panel. Zoom-in view of the bottom left inset in the top graph. The point corresponding to allopregnanolone withdrawal and related a value is indicated. The horizontal red lines indicate the values taken by the bifurcation point at half-maximal glutamatergic strength (a^=0.116,b=0.5), and for a 20% rise of b above this level (a^=0.16,b=0.6). At allopregnanolone withdrawal, the thalamocortical loop system is still monostable for b = 0.5 (a>a^), but it becomes bistable for b = 0.6 (a<a^).
Fig 3 Relationship between estimated allopregnanolone brain levels and the strength of GABAergic transmission, expressed by the coefficient a, as derived from Eq (4). Top panel. The pink band indicates the transition zone separating two ranges of allopregnanolone where different effects on the GABAA receptor are prevalent: In the lower range the effect on GABAA α4 subunit expression, while in the higher range the positive allosteric modulation on GABAA activity. The points corresponding to allopregnanolone concentrations and a values at the follicular and luteal phases, and the value of the bifurcation point at the maximal glutamatergic strength (a^=0.265,b=1), are indicated. Bottom panel. Zoom-in view of the bottom left inset in the top graph. The point corresponding to allopregnanolone withdrawal and related a value is indicated. The horizontal red lines indicate the values taken by the bifurcation point at half-maximal glutamatergic strength (a^=0.116,b=0.5), and for a 20% rise of b above this level (a^=0.16,b=0.6). At allopregnanolone withdrawal, the thalamocortical loop system is still monostable for b = 0.5 (a>a^), but it becomes bistable for b = 0.6 (a<a^).CC BY · PubMed Central
Fig 4 Simplified diagram of the feedback loop system formed by the HPA and HPG axes. Line ends as in Fig 1.
Fig 4 Simplified diagram of the feedback loop system formed by the HPA and HPG axes. Line ends as in Fig 1.CC BY · PubMed Central
Fig 5 Phase portrait of the dynamic system representing the HPG-HPA interaction according to the diagram of Fig 4. The trajectories of the dynamic system have been computed with MATLAB by using Eqs (7) and (8) with the parameters reported in Table 5. Initial conditions have been randomly selected to be representative of different possible evolutions of the system. Each trajectory converges to one of the three stable equilibrium points (black dots). Black lines mark the boundaries between the basins of attraction of the three equilibria. The basin of attraction of the equilibrium point with high HPA and low HPG activity (which attracts the red trajectories) is assumed to represent the functional states leading to the onset of FM.
Fig 5 Phase portrait of the dynamic system representing the HPG-HPA interaction according to the diagram of Fig 4. The trajectories of the dynamic system have been computed with MATLAB by using Eqs (7) and (8) with the parameters reported in Table 5. Initial conditions have been randomly selected to be representative of different possible evolutions of the system. Each trajectory converges to one of the three stable equilibrium points (black dots). Black lines mark the boundaries between the basins of attraction of the three equilibria. The basin of attraction of the equilibrium point with high HPA and low HPG activity (which attracts the red trajectories) is assumed to represent the functional states leading to the onset of FM.CC BY · PubMed Central
Fig 6 Global representation of transitions leading to FM pathogenesis according to our neuroendocrine multistable model. Top strip: Phase portrait of the HPA/HPG loop system, showing three stable equilibria (main graph). The lower-left (circadian) and lower-right (pathogenic) equilibria are connected with corresponding points on the graphs of the relationship between allopregnanolone brain concentration and GABAergic strength a (side graphs). The red lines in the side graphs indicate the bifurcation values a^, showing that the lower-right equilibrium point in the phase space leads to a value a<a^. Bottom strip: The pain processing thalamocortical loop (left diagram), under the influence of the lower-right equilibrium point of the endocrine loop, crosses its bifurcation point, which leads to the appearance of two stable equilibria in its own phase space (right diagram). The high-firing-rate equilibrium represents the chronic pain condition and has a much wider basin of attraction. Therefore, once bistability has arisen, the thalamocortical system is prone to converging to the high-firing-rate equilibrium, thus causing the onset of FM symptoms. The variables considered in the endocrine phase space (top) represent the percent activities of the endocrine axes, e.g. estimated from the plasma levels of cortisol (HPA) and progesterone (HPG). The phase space shown in the bottom strip is a bidimensional projection on the VPL/SSC plane of the three-dimensional thalamocortical phase space, and the graph axes represent the percent firing rate above baseline of the thalamic ventroposterolateral nucleus (VPL) and the primary somatosensory cortex (SSC).
Fig 6 Global representation of transitions leading to FM pathogenesis according to our neuroendocrine multistable model. Top strip: Phase portrait of the HPA/HPG loop system, showing three stable equilibria (main graph). The lower-left (circadian) and lower-right (pathogenic) equilibria are connected with corresponding points on the graphs of the relationship between allopregnanolone brain concentration and GABAergic strength a (side graphs). The red lines in the side graphs indicate the bifurcation values a^, showing that the lower-right equilibrium point in the phase space leads to a value a<a^. Bottom strip: The pain processing thalamocortical loop (left diagram), under the influence of the lower-right equilibrium point of the endocrine loop, crosses its bifurcation point, which leads to the appearance of two stable equilibria in its own phase space (right diagram). The high-firing-rate equilibrium represents the chronic pain condition and has a much wider basin of attraction. Therefore, once bistability has arisen, the thalamocortical system is prone to converging to the high-firing-rate equilibrium, thus causing the onset of FM symptoms. The variables considered in the endocrine phase space (top) represent the percent activities of the endocrine axes, e.g. estimated from the plasma levels of cortisol (HPA) and progesterone (HPG). The phase space shown in the bottom strip is a bidimensional projection on the VPL/SSC plane of the three-dimensional thalamocortical phase space, and the graph axes represent the percent firing rate above baseline of the thalamic ventroposterolateral nucleus (VPL) and the primary somatosensory cortex (SSC).CC BY · PubMed Central

Verification

Claims the paper makes

55 Valid · 2 Not valid · 33 Not checked · 48 Own results and interpretations

73 more claims · 25 with their cited sources checked

Create a free account to see all 138 claims and to verify the 11 references still open.

See all claims — free account
  • It may state two separate claims as one. 41
  • Probably not a substantial claim. 23
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Cited by

See all 14

Metadata

Authors
Demori, I., Losacco, S., Giordano, G., Mucci, V., Blanchini, F., & Burlando, B.
Affiliations
  • University of Genoa (IT)
  • University of Trento (IT)
  • Western Sydney University (AU)
  • University of Udine (IT)
Corresponding author
Giordano, Giulia
Venue
PLOS ONE
Published
2024-07-11
Volume
19
Issue
7
Pages
e0303573
ISSN
1932-6203 (ISSN-L)
OpenAlex
W4400527963
Cited by
14
References
166
Citations by year
2026: 5 · 2025: 7 · 2024: 2
FWCI
4.09
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Institutional Research Information System (Università degli Studi di Trento) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion, other-oa)
Funders
HORIZON EUROPE European Research Council (101076926)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
fibromyalgia, pathogenesis, multistability, bistability, bifurcation, hypothalamic-pituitary-gonadal axis, hypothalamic-pituitary-adrenal axis, allopregnanolone, neurosteroids, cortisol, thalamocortical loop, ventroposterolateral thalamic nucleus, thalamic reticular nucleus, primary somatosensory cortex, GABAergic neurotransmission, glutamatergic neurotransmission, stress, sex differences, chronic pain
MeSH terms
Female, Fibromyalgia, Humans, Hypothalamo-Hypophyseal System, Models, Biological, Neurosecretory Systems, Pituitary-Adrenal System

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.